Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.
Somewhat later than expected, the US may soon be able to offer Covid-19 vaccinations for children five years of age and younger, something parents have repeatedly...
An updated version of Moderna’s Covid-19 vaccine is claimed to produce a stronger immune response against major variants of the coronavirus, including omicron and delta...
What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...
The US Food and Drug Administration has scheduled a virtual meeting of its scientific advisory panel for Apr. 6 to discuss the prospect of future Covid-19 boosters and...
Moderna has announced it will begin conducting human trials for vaccines against 15 threatening viruses and other pathogens by 2025 as part of a global public health...
US biotech Moderna has announced plans to expand in Europe and Asia. The expansions come as the company continues to scale up manufacturing and distribution of its Covid...
February kicked off with a major publicity coup for US vaccine maker Novavax, based in the state of Maryland. Its Covid-19 vaccine was granted conditional marketing...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | Twitter